PANW Palo Alto Networks | $315.69 -2.5% | 5/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 5/21/2024 |
SVRA Savara | $4.22 +1.2% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.50 -> $11.00 | Low | View details for Oppenheimer rating of Savara (NASDAQ:SVRA) on 5/21/2024 |
ALLO Allogene Therapeutics | $2.85 +10.0% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $13.00 | Low | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 5/21/2024 |
ATXS Astria Therapeutics | $9.25 -3.5% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $25.00 | Low | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 5/21/2024 |
WIX Wix.com | $171.56 +2.1% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Wix.com (NASDAQ:WIX) on 5/21/2024 |
SACH Sachem Capital | $3.19 -0.3% | 5/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.50 | N/A | View details for Oppenheimer rating of Sachem Capital (NYSEAMERICAN:SACH) on 5/20/2024 |
|
NVDA NVIDIA | $947.09 -0.1% | 5/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 5/17/2024 |
CFLT Confluent | $31.13 -2.8% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $37.00 | Low | View details for Oppenheimer rating of Confluent (NASDAQ:CFLT) on 5/17/2024 |
CAPR Capricor Therapeutics | $6.21 -1.4% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $14.00 | Low | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/17/2024 |
DE Deere & Company | $386.31 -1.3% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $456.00 -> $456.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 5/16/2024 |
HASI Hannon Armstrong Sustainable Infrastructure Capital | $32.16 +1.3% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) on 5/16/2024 |
CSCO Cisco Systems | $47.05 -0.2% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $58.00 | Low | View details for Oppenheimer rating of Cisco Systems (NASDAQ:CSCO) on 5/16/2024 |
EPIX ESSA Pharma | $6.12 -1.9% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of ESSA Pharma (NASDAQ:EPIX) on 5/16/2024 |
MNDY monday.com | $237.21 +3.4% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $250.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 5/16/2024 |
ADI Analog Devices | $216.43 -0.5% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $215.00 -> $245.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 5/16/2024 |
PACS PACS Group | $27.76 -2.8% | 5/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $32.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/15/2024 |
STRO Sutro Biopharma | $4.69 +0.2% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 5/15/2024 |
VECO Veeco Instruments | $40.59 -0.1% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $45.00 | Low | View details for Oppenheimer rating of Veeco Instruments (NASDAQ:VECO) on 5/15/2024 |
VYGR Voyager Therapeutics | $8.38 -0.8% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Voyager Therapeutics (NASDAQ:VYGR) on 5/15/2024 |
WDAY Workday | $258.01 -0.6% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $350.00 -> $320.00 | Low | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 5/15/2024 |
LAND Gladstone Land | $13.85 +4.4% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $16.00 | Low | View details for Oppenheimer rating of Gladstone Land (NASDAQ:LAND) on 5/15/2024 |
JACK Jack in the Box | $53.27 -1.6% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $75.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 5/15/2024 |
ALC Alcon | $88.22 +0.1% | 5/15/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $103.00 | N/A | View details for Oppenheimer rating of Alcon (NYSE:ALC) on 5/15/2024 |
AGYS Agilysys | $101.98 -0.5% | 5/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 5/14/2024 |
URGN UroGen Pharma | $13.41 +3.9% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $32.00 | Low | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 5/14/2024 |
SRPT Sarepta Therapeutics | $128.39 -1.9% | 5/14/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $180.00 | Low | View details for Oppenheimer rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/14/2024 |
FULC Fulcrum Therapeutics | $7.44 -3.4% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $14.00 | Low | View details for Oppenheimer rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/14/2024 |
ACHV Achieve Life Sciences | $5.15 +1.8% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $11.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/13/2024 |
CTOS Custom Truck One Source | $4.66 -1.7% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 5/13/2024 |
MNMD Mind Medicine (MindMed) | $8.45 +3.9% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/13/2024 |
SLNO Soleno Therapeutics | $44.93 -4.4% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $59.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/13/2024 |
TYRA Tyra Biosciences | $18.33 -2.1% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $28.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 5/13/2024 |
VOR Vor Biopharma | $1.75 +0.6% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $10.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 5/13/2024 |
CRSP CRISPR Therapeutics | $54.56 -1.6% | 5/10/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $102.00 -> $95.00 | Low | View details for Oppenheimer rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/10/2024 |
ZURA Zura Bio | $5.55 -7.3% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $21.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 5/10/2024 |
SPB Spectrum Brands | $94.62 +0.9% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $115.00 | Low | View details for Oppenheimer rating of Spectrum Brands (NYSE:SPB) on 5/10/2024 |
EVCM EverCommerce | $10.63 -2.1% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 5/10/2024 |
ARRY Array Technologies | $10.83 +0.8% | 5/10/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $20.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 5/10/2024 |
TARS Tarsus Pharmaceuticals | $38.35 -1.0% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/9/2024 |
CYTK Cytokinetics | $60.45 -0.2% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $106.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 5/9/2024 |
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad) Right now, there’s over $6 trillion in potential investment money waiting on the sidelines.
That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… |
VRDN Viridian Therapeutics | $12.97 -4.1% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $31.00 | Low | View details for Oppenheimer rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024 |
MCRB Seres Therapeutics | $0.92 -3.1% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 5/9/2024 |
BWAY BrainsWay | $5.40 -1.6% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $11.00 | Low | View details for Oppenheimer rating of BrainsWay (NASDAQ:BWAY) on 5/9/2024 |
IAC IAC | $51.88 -2.8% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $75.00 | Low | View details for Oppenheimer rating of IAC (NASDAQ:IAC) on 5/9/2024 |
APP AppLovin | $84.11 -0.5% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $97.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 5/9/2024 |
CCSI Consensus Cloud Solutions | $19.54 -2.9% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 5/9/2024 |
CRBP Corbus Pharmaceuticals | $46.03 -5.2% | 5/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $60.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/8/2024 |
SAR Saratoga Investment | $23.50 +0.5% | 5/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $24.00 -> $23.00 | Low | View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 5/8/2024 |
PTON Peloton Interactive | $3.34 -14.6% | 5/7/2024 | Reiterated by | Oppenheimer | - | Outperform | | Low | View details for Oppenheimer rating of Peloton Interactive (NASDAQ:PTON) on 5/7/2024 |
FRPT Freshpet | $125.33 +0.4% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $135.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 5/7/2024 |
RXST RxSight | $63.10 +0.7% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $72.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 5/7/2024 |
ULTA Ulta Beauty | $379.13 -1.9% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $475.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/7/2024 |
PLRX Pliant Therapeutics | $14.73 -2.6% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $48.00 | Low | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024 |
CRVS Corvus Pharmaceuticals | $2.24 -1.8% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $8.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/7/2024 |
BOWL Bowlero | $12.04 +0.3% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $15.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 5/7/2024 |
ZETA Zeta Global | $18.01 +2.2% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $18.00 | Low | View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 5/7/2024 |
IART Integra LifeSciences | $26.99 +0.0% | 5/7/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Integra LifeSciences (NASDAQ:IART) on 5/7/2024 |
WSC WillScot Mobile Mini | $42.17 +1.5% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $53.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 5/6/2024 |
ACAD ACADIA Pharmaceuticals | $14.99 -0.7% | 5/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $19.00 -> $19.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/6/2024 |
ALDX Aldeyra Therapeutics | $4.03
| 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024 |
DYN Dyne Therapeutics | $33.51 -5.3% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
RLAY Relay Therapeutics | $7.30 +7.7% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $25.00 | Low | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 5/6/2024 |
ENSG The Ensign Group | $119.25 -0.3% | 5/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $135.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 5/6/2024 |
TRMB Trimble | $57.25 -0.1% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 5/6/2024 |
PACS PACS Group | $27.76 -2.8% | 5/6/2024 | Initiated by | Oppenheimer | - | Outperform | $31.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/6/2024 |
AGCO AGCO | $108.14 -1.8% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $154.00 -> $145.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 5/3/2024 |
APTV Aptiv | $82.03 +0.1% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $148.00 -> $145.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 5/3/2024 |
BWA BorgWarner | $36.69 -0.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Oppenheimer rating of BorgWarner (NYSE:BWA) on 5/3/2024 |
CI The Cigna Group | $336.12 +0.8% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $400.00 | Low | View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
NET Cloudflare | $74.87 -1.0% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $110.00 | Low | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 5/3/2024 |
COIN Coinbase Global | $226.03 +0.4% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $276.00 -> $282.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/3/2024 |
CTVA Corteva | $56.59 -0.3% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $69.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 5/3/2024 |
THG The Hanover Insurance Group | $137.01 -0.3% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $165.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 5/3/2024 |
ITRI Itron | $106.82 -2.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $110.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 5/3/2024 |
KYMR Kymera Therapeutics | $35.86 -0.4% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $52.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 5/3/2024 |
MRNA Moderna | $140.20 -0.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $163.00 | Low | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 5/3/2024 |
SPXC SPX Technologies | $143.82 +0.0% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $140.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 5/3/2024 |
SPT Sprout Social | $30.52 -4.1% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $76.00 -> $43.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
WCC WESCO International | $187.50 -0.3% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $200.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 5/3/2024 |
XYL Xylem | $144.99 -0.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $147.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 5/3/2024 |
ZBH Zimmer Biomet | $119.10 +0.0% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $155.00 | Low | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 5/3/2024 |
ARCC Ares Capital | $21.48 +0.7% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $22.00 | Low | View details for Oppenheimer rating of Ares Capital (NASDAQ:ARCC) on 5/2/2024 |
TCPC BlackRock TCP Capital | $10.91 +0.5% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of BlackRock TCP Capital (NASDAQ:TCPC) on 5/2/2024 |
CG The Carlyle Group | $43.96 +1.4% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $68.00 | Low | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 5/2/2024 |
FSLR First Solar | $207.47 +5.7% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $269.00 -> $271.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 5/2/2024 |
GNRC Generac | $152.67 +1.0% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $145.00 | Low | View details for Oppenheimer rating of Generac (NYSE:GNRC) on 5/2/2024 |
NGVT Ingevity | $50.05 -1.9% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $58.00 | Low | View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 5/2/2024 |
INTA Intapp | $36.85 0.0% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $42.00 | Low | View details for Oppenheimer rating of Intapp (NASDAQ:INTA) on 5/2/2024 |
JCI Johnson Controls International | $72.33 +2.4% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $70.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 5/2/2024 |
NBIX Neurocrine Biosciences | $140.98 -0.5% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $216.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad) Right now, there’s over $6 trillion in potential investment money waiting on the sidelines.
That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… |
RSI Rush Street Interactive | $9.04 +2.8% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $10.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 5/2/2024 |
UTHR United Therapeutics | $274.74 +0.0% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $375.00 -> $400.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024 |
FRSH Freshworks | $13.68 -3.3% | 5/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
NXPI NXP Semiconductors | $273.43 -0.1% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $295.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 5/1/2024 |
RSG Republic Services | $186.00 +0.0% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $202.00 -> $204.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 5/1/2024 |
DAN Dana | $14.00 -0.5% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Oppenheimer rating of Dana (NYSE:DAN) on 5/1/2024 |
DENN Denny's | $7.57 -2.2% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/1/2024 |
TREE LendingTree | $43.86 -3.8% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 5/1/2024 |
AMZN Amazon.com | $181.85 -0.9% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024 |
TMDX TransMedics Group | $139.02 +0.3% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $125.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/1/2024 |
LOVE Lovesac | $26.98 -0.9% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $35.00 | Low | View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 5/1/2024 |
DPZ Domino's Pizza | $514.33 -0.3% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $530.00 -> $580.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
GS The Goldman Sachs Group | $470.07 +1.5% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $479.00 -> $517.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/30/2024 |
JEF Jefferies Financial Group | $47.20 +0.3% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $56.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/30/2024 |
MS Morgan Stanley | $101.55 +1.2% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $101.00 -> $105.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/30/2024 |
BAC Bank of America | $39.15 +0.9% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/30/2024 |
C Citigroup | $64.00 +1.3% | 4/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $86.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/30/2024 |
CNC Centene | $78.04 +0.6% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Oppenheimer rating of Centene (NYSE:CNC) on 4/29/2024 |
EXPE Expedia Group | $112.10 -1.9% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 4/29/2024 |
ROP Roper Technologies | $539.81 -1.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/29/2024 |
SFM Sprouts Farmers Market | $79.41 +0.3% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprouts Farmers Market (NASDAQ:SFM) on 4/29/2024 |
UBER Uber Technologies | $64.09 -0.9% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 4/29/2024 |
URI United Rentals | $692.42 -1.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of United Rentals (NYSE:URI) on 4/29/2024 |
WT WisdomTree | $9.69 +1.8% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/29/2024 |
LECO Lincoln Electric | $225.01 -1.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Lincoln Electric (NASDAQ:LECO) on 4/29/2024 |
BIIB Biogen | $227.04 -2.0% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/29/2024 |
DASH DoorDash | $112.27 -1.5% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $150.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 4/29/2024 |
ETSY Etsy | $63.83 -0.5% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 4/29/2024 |
HCA HCA Healthcare | $319.72 -1.6% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $345.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 4/29/2024 |
CART Maplebear | $32.37 -1.7% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $48.00 | Low | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 4/29/2024 |
OSIS OSI Systems | $143.14 +1.8% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $160.00 | Low | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 4/29/2024 |
POOL Pool | $368.30 +0.0% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $436.00 -> $416.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/29/2024 |
GOOGL Alphabet | $176.82 -0.1% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
TEAM Atlassian | $178.57 -0.7% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $250.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024 |
CSL Carlisle Companies | $423.60 +0.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $412.00 -> $430.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024 |
CARR Carrier Global | $66.22 +0.4% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $64.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024 |
DOV Dover | $185.15 +0.0% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $187.00 -> $197.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024 |
RMD ResMed | $217.86 -0.4% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $200.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024 |
SPGI S&P Global | $440.12 +0.5% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $482.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024 |
TDOC Teladoc Health | $11.96 -2.8% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $21.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024 |
TPH Tri Pointe Homes | $39.13 -1.5% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $46.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024 |
WM Waste Management | $208.47
| 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $228.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024 |
TYL Tyler Technologies | $496.71 +0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $500.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024 |
VRT Vertiv | $99.33 +0.0% | 4/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $96.00 -> $98.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024 |
CMG Chipotle Mexican Grill | $3,175.06 0.0% | 4/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $2,825.00 -> $3,300.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
CYH Community Health Systems | $3.67 +0.8% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $4.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024 |
HUM Humana | $355.59 +0.1% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $415.00 -> $370.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024 |
META Meta Platforms | $462.96 -1.3% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $585.00 -> $500.00 | N/A | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
ENPH Enphase Energy | $111.19 -2.0% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $134.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
INCY Incyte | $57.15 -0.1% | 4/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $84.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024 |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
NBIX Neurocrine Biosciences | $140.98 -0.5% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
NEP NextEra Energy Partners | $33.86 -0.2% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024 |
PNR Pentair | $84.60 0.0% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024 |
PHM PulteGroup | $118.15 -0.9% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $143.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024 |
TSLA Tesla | $180.85 +3.4% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024 |
TXN Texas Instruments | $198.92 -0.1% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
UPS United Parcel Service | $145.69 -1.3% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $157.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024 |
V Visa | $275.34 -1.1% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $297.00 -> $299.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024 |
MSCI MSCI | $508.77 -0.7% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024 |
EA Electronic Arts | $128.35 +0.0% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $150.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024 |
GANX Gain Therapeutics | $2.53 +0.8% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024 |
TTWO Take-Two Interactive Software | $151.55 +0.4% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024 |
VZ Verizon Communications | $39.61 -1.3% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024 |
CHD Church & Dwight | $106.67 +0.2% | 4/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024 |
ATRC AtriCure | $22.45 +0.6% | 4/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $32.00 | Low | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024 |
TARA Protara Therapeutics | $3.03 +1.3% | 4/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024 |
WT WisdomTree | $9.69 +1.8% | 4/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024 |
KYMR Kymera Therapeutics | $35.86 -0.4% | 4/22/2024 | Initiated by | Oppenheimer | - | Outperform | $53.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024 |
GILD Gilead Sciences | $66.98 -1.4% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024 |
NFLX Netflix | $644.05 +0.5% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
SBUX Starbucks | $77.71 +0.2% | 4/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
BIIB Biogen | $227.04 -2.0% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024 |
EFX Equifax | $236.90 -5.9% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $291.00 -> $272.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024 |
USB U.S. Bancorp | $41.00 +0.3% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $54.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024 |
XYL Xylem | $144.99 -0.5% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $142.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024 |
SAGE Sage Therapeutics | $11.29 +1.0% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 -> $17.00 | Low | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024 |
TRNS Transcat | $138.24 +11.4% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024 |
AOS A. O. Smith | $85.25 -0.7% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024 |
WMS Advanced Drainage Systems | $177.77 +0.2% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $180.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024 |
AVNT Avient | $45.58
| 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $49.00 | Low | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024 |
CSL Carlisle Companies | $423.60 +0.9% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $405.00 -> $412.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024 |
CARR Carrier Global | $66.22 +0.4% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $63.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024 |
CAT Caterpillar | $358.36 -1.2% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024 |
DOV Dover | $185.15 +0.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024 |
IEX IDEX | $217.21 -1.2% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024 |
JCI Johnson Controls International | $72.33 +2.4% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $71.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024 |
SPT Sprout Social | $30.52 -4.1% | 4/18/2024 | Initiated by | Oppenheimer | - | Outperform | $76.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 4/18/2024 |
ORCL Oracle | $124.63 +0.1% | 4/18/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 4/18/2024 |
MWA Mueller Water Products | $19.12 +0.2% | 4/18/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 4/18/2024 |
AMRC Ameresco | $29.19 +4.5% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024 |
BLZE Backblaze | $6.72 -5.4% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024 |
BAC Bank of America | $39.15 +0.9% | 4/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $45.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024 |
FSLR First Solar | $207.47 +5.7% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024 |
MS Morgan Stanley | $101.55 +1.2% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $101.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024 |
PANW Palo Alto Networks | $315.69 -2.5% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $305.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
QMCO Quantum | $0.54 -1.8% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024 |
TWLO Twilio | $60.09 -1.3% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024 |
VIRX Viracta Therapeutics | $0.78 -3.4% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024 |
OBDE Blue Owl Capital Co. III | $15.88
| 4/17/2024 | Initiated by | Oppenheimer | - | Outperform | $16.00 | Low | View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024 |
SKIL Skillsoft | $8.87 -0.9% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
AGCO AGCO | $108.14 -1.8% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $154.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024 |
CTVA Corteva | $56.59 -0.3% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $62.00 -> $67.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024 |
GS The Goldman Sachs Group | $470.07 +1.5% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $446.00 -> $479.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024 |
AVTX Avalo Therapeutics | $11.05 -0.5% | 4/16/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | | Low | View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024 |
C Citigroup | $64.00 +1.3% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $87.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024 |
EL Estée Lauder Companies | $131.10 0.0% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024 |
JPM JPMorgan Chase & Co. | $197.72 +1.1% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $217.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024 |
VRTX Vertex Pharmaceuticals | $438.66 -1.6% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $500.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024 |
VERU Veru | $1.49 +4.6% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024 |
WFC Wells Fargo & Company | $61.33 +1.0% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024 |
ZWS Zurn Elkay Water Solutions | $32.66 +0.2% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024 |
RVMD Revolution Medicines | $38.17 -4.6% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $45.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024 |
SKYE Skye Bioscience | $11.91 -0.8% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
SKYE Skye Bioscience | $12.00 -0.4% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
QTTB Q32 Bio | $29.73 -1.6% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024 |
LVRO Lavoro | $5.80 +1.8% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $11.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024 |
XPO XPO | $107.88 -2.4% | 4/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024 |
KMX CarMax | $71.77 -1.1% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024 |
CUE Cue Biopharma | $1.85 -1.1% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024 |
EFX Equifax | $236.90 -5.9% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $273.00 -> $291.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $38.03 -1.8% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
MSCI MSCI | $508.77 -0.7% | 4/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $659.00 -> $648.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024 |
SEIC SEI Investments | $68.27 +0.4% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024 |
TRU TransUnion | $77.43 -1.8% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024 |
APP AppLovin | $84.11 -0.5% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $85.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024 |
META Meta Platforms | $462.96 -1.3% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $585.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024 |
GOOG Alphabet | $178.42 0.0% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024 |
HCI HCI Group | $101.06 -1.2% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024 |
THG The Hanover Insurance Group | $137.01 -0.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024 |
SIGI Selective Insurance Group | $97.09 +0.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 | Low | View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024 |
LULU Lululemon Athletica | $323.33 -1.1% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024 |
TRV Travelers Companies | $216.87 +0.6% | 4/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024 |
AXP American Express | $242.50 +0.1% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024 |
ANGO AngioDynamics | $5.90 +1.5% | 4/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024 |
VRT Vertiv | $99.33 +0.0% | 4/5/2024 | Initiated by | Oppenheimer | - | Outperform | $96.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024 |
GENI Genius Sports | $5.49 -0.2% | 4/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024 |
ULTA Ulta Beauty | $379.13 -1.9% | 4/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $500.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024 |
COIN Coinbase Global | $226.03 +0.4% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $276.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024 |
AYI Acuity Brands | $263.28 +0.5% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $315.00 | Low | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024 |
BMEA Biomea Fusion | $11.72 -7.1% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024 |
CMCSA Comcast | $39.46 +0.6% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024 |
STRO Sutro Biopharma | $4.69 +0.2% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
TMUS T-Mobile US | $163.88 0.0% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $190.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024 |
VZ Verizon Communications | $39.61 -1.3% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024 |
ALDX Aldeyra Therapeutics | $4.03
| 4/3/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024 |
AIT Applied Industrial Technologies | $200.40 -0.3% | 4/2/2024 | Initiated by | Oppenheimer | - | Outperform | $235.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024 |
MVST Microvast | $0.41 -0.1% | 4/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $4.00 | Low | View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024 |
MCO Moody's | $413.12 +0.1% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $411.00 -> $424.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024 |
SPGI S&P Global | $440.12 +0.5% | 4/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $480.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024 |
TSLA Tesla | $180.85 +3.4% | 4/2/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024 |
JEF Jefferies Financial Group | $47.20 +0.3% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $54.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024 |
ACHV Achieve Life Sciences | $5.15 +1.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024 |
CALC CalciMedica | $5.36 -0.7% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
CTAS Cintas | $696.65 -0.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024 |
DRRX DURECT | $1.12 +7.7% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024 |
KALA KALA BIO | $6.64 +0.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024 |
CATX Perspective Therapeutics | $1.56 -4.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1.20 -> $1.50 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 4/1/2024 |
RH RH | $273.72 -2.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024 |
SMTC Semtech | $41.31 +2.7% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024 |
ZURA Zura Bio | $5.55 -7.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024 |